chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 01-MAY-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number reported as R021930 with expiration date in 18-JUN-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  Lot number R021930 is an invalid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
Benadryl 50 mg po and Zofran 4 mg ODT given with no further lightheadedness or nausea.  VSS.
Pt. started to feel dizzy at 2:27. Vitals were taken at 2:28, Temp 97.8, O 98% H/R 87 . At 2:33 Cold compress on back of neck pt cont. feel dizzy/hot, V/S O 98%, H/R 84 , R. 16, B/P 130/80. 2:40 pt complains of chest tightness / numbness of body . V/S at 2:40 B/P 135/85 HR 80 O 98% Temp 97.8. 911 was called at 2:41. V/S at 2:50 O 99%, HR 92, BP 145/82 R16. Pt complains of dizziness & face numbness at 2:52. EMS arrived at 2:55. EMS transported pt to hospital at 3:02. Pt was alert and oriented.
Cellulitis at 10 days post immunization. Tx. PO KEFLEX 8ml/TID 4.0 cm x 2.5 cm well demarcated erythematous rxn, possible developing abscess.
I just read an article about "COVID arm" and I believe that this is what I had! I had a softball sized, red circle around where the shot was given. It was swollen for about 1 week following administration. It also felt like there was a hard marble in my arm. Not very painful at all. I have a picture I would be happy to submit!
He developed a circular red rash "like a ringworm" on right upper arm later in day 11/3/11. When called for advice, was told to observe and go to ER if got worse. Rash developed down right leg that night and went to ER. By time MD saw him, rash had dissipated. Treated with BENADRYL - no sequelae.
finger tips swollen and tingling; finger tips are swollen and tingling; head was hurting; cardiac event; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 60 year-old female patient received bnt162b2 (BNT162B2), administration date 22Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "finger tips swollen and tingling"; PARAESTHESIA (non-serious), outcome "unknown", described as "finger tips are swollen and tingling"; HEADACHE (non-serious), outcome "unknown", described as "head was hurting"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "cardiac event". The event "cardiac event" was evaluated at the emergency room visit.  Additional information: the patient was the reporter's mom. Caller reports that patient experienced a cardiac event and was in the emercgency room till 2 AM. Caller reports that his mom finger tips are swollen and tingling, and the left side of her head was hurting.   No follow-up attempts are possible. No further information is expected.
swelling around right eye; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling around right eye) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced EYE SWELLING (swelling around right eye). At the time of the report, EYE SWELLING (swelling around right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not reported.   Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Additional information has been requested.
3/23 Mother called to report patient developed redness, selling in left upper arm, axilla, left side of upper chest on Sunday 3/21. Take to urgent care dx Cellulitis on antibiotics. WBC normal. Noted record shows unit dose DTaP given IM with 1" needle when Tdap should have been administered.
Malaise; Achiness; Dizziness; Diarrhea; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea) and CHILLS (Chills) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea), CHILLS (Chills) and HEADACHE (Headache) had resolved.            No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable
Information has been received from a nurse practitioner concerning a male consumer who on an unspecified date was vaccinated with a first dose of 0.65ml ZOSTAVAX. Subsequently, four days after being vaccinated the patient developed shingles. The patient was seen by the nurse practitioner, it was unspecified if lab studies were performed. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
PATIENT WAS ADMINISTERED DOSE 1 OF MODERNA VACCINE ON 1-27-2021.  Patient reported minor soreness next day. however on 2-5-2021 patient stated he noticed a red rash just below the location of the vaccine administration site
Child received pediatric dose of  Pfizer COVID vaccine when he should have received a adolescent/adult dose
Throat swelling, weak in the knees within a few hours of administration. Site of injection warm and swollen.
On the Monday the 3/28/22, I woke up with congestion, runny nose, and the next day I developed a cough and it went deeply into my chest and I worked the whole week I am a therapist and saw 30 people all week and they knew I had a cold. I was taking Mucinex and had minor improvement on Tuesday and on Friday I walked into the kitchen and my wife was cooking a pan on onions and garlic and I couldn't smell it and tested and I was positive for COVID-19. My wife didn't get it and since I am fine and my sense of smell came back after 9 days. I have described myself to people at 100% as of last week.
rash on neck, stomach; mild weakness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on neck, stomach) and ASTHENIA (mild weakness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on neck, stomach) and ASTHENIA (mild weakness). At the time of the report, RASH (rash on neck, stomach) and ASTHENIA (mild weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided. Treatment information not provided
88 Y male with h/o HTN, HLD, MVR in 2014 with Carpentier-Edwards Physio Mitral Annulop 32 mm, A fib on pradaxa, BPH, mild COPD and history of TIA 2016 presenting with SOB and AMS from baseline, admitted for COVID pneumonia.    COVID Pneumonia Exposed at least 4 days PTA. Symptom onset on 12/30/21. Tested positive on 12/31/21. D-dimer was elevated. ED ordered CTA which was neg for PE. During the 36 hours of admission, he received Decadron 6mg x1 and remdesivir x2. He did not require supplemental oxygen and was able to ambulate without SpO2 desating prior to discharge. He was discharged with a COVID kit which includes a pulse ox to continue self-assessing at home, should symptoms worsen.     Fluid overload | Murmur | MVR 2008 | HFpEF 50-55% Mitral Valve Repair Annuloplasty Neochords (PTFE): 4 inserted Mitral Prosthesis (Annuloplasty device) : 4450## - Carpentier-Edwards Physio Mitral Annulop, 32mm Serial# 4365268 Has increased swelling, SOB/DOE and dizziness. Planned for VA workup for progressive heart disease but not done yet. Received Lasix 20 IV x3 while admitted with >5L UOP response and significant decrease in LE edema.  - TTE to be done at clinic, already scheduled - discharged on Lasix 20 po daily, titration per PCP, f/u K/Cr in 5 days   HTN | HLD | A fib -Continue PTA amlodipine, losartan, atorvastatin and carvediol and apixaban 5 BID.
headache from crown down to ears; runny nose; temp. of 101.5; scratchy throat; nausea; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), NAUSEA (nausea), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), NAUSEA (nausea), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Excedrin   Most recent FOLLOW-UP information incorporated above includes: On 23-Feb-2021: No specific follow-up information recorded.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-JAN-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine underwent a temperature excursion of the lowest recorded temperature of 34 degrees Fahrenheit for 376 hours. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient vaccinated around 6:20am.  Nurse started to document immediately after vaccination and noticed sponsor did not consent to vaccination.  No adverse effects noted.  Family notified.
Malasia, weakness, fever at times 100.6, chills, diarrhea
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unspecified dates starting on or after 21-OCT-2015, the patients were administered an unspecified number of improperly stored doses of M-M-R II (lot K024035, expiration date 26-NOV-2016, lot L003856, expiration date 02-MAY-2017, lot L009214, expiration date 17-MAR-2017, lot  L012479, expiration date 10-APR-2017, albumin status was rHA, strength, dose and route unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Hard lump with swelling,  hot to touch with itching at injection site on left upper arm .   Started this afternoon at approx 1600.  Took 25mg benadryl No change currently
Information has been received from a Registered nurse concerning a patient who was vaccinated with a dose of Varivax which had been exposed to + 23 deg F for approximately 16 hours. Subsequently the patient developed mild chickenpox. The patient's outcome was not reported. Additional information has been requested.
Fever, diarrhea after rotavirus immunization fever up to 101 degree F, diarrhea-non bloody, non mucousy.
Received vaccine at 18:45 on 01/19/2020  Woke up at 10:00 01/20/2021 after approx 8-9 hours of sleep with symptoms: Nausea  Headache Dizziness  Dry Cough Chest/Lung Tightness Full Body Aches Fatigue/Lethargy
pt recv vax 13AUG96 & 17MAR97 pt devel chickenpox comprised of 250-350 lesions & presented to MD;f/u info reported that pt subsequently recovered;
seen @ ER 1 1/2hr p/vax;diffuse red rash & hives;no stridor;no sneezing;some swelling around lips;
Pt felt pain right after the shot and it's getting worse 1 month later still can't lift heavy item. Feeling pain when move, stretch, turn, putting clothes or sleep on left arm.
Burning sensation radiating from right arm into neck and back across both shoulders with itching sensation; nausea; vomitting; feverous feeling; pain in neck and right arm; weakness; malaise
9/19/11: site immediately bruised after immunization given - ice pack to site. 1900: c/o fever 101 degrees - 102 degrees c/o pain: onset at time of shot, progressively worse; onset redness; ibuprofen 600 mg Q 5 hrs for fever, 9/20/11: c/o fever 102 degrees - 104 degrees. 9/21/11 increased redness, increased warmth at site. Seen in clinic. Rx cephalexin 500 mg QID x 7 d; site redness about 3" x 4 " (L) upper arm.
Within 12 hrs of admin vaccine, became very nauseated extremely exhausted and joints were stiff and painful in both arms. The next day nausea continued and all joints including lumbar spine were incredibly stiff and sore and unable to bend. Stiffness and soreness took 3 days before joints would move normally.
Information has been received from a certified medical assistant concerning a 77 year old female patient who on 25-SEP-2007, was vaccinated with a dose of Pneumovax 23 (Lot# 657528/0733U). On approximately 27-SEP-2007 two days after the vaccination, the patient was found fainted on her floor. The patient was admitted to the hospital from the emergency room. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Information has been received from a physician concerning a 25 yr old male with no illness at the time of the vaccination and no pre-existing allergies, birth defect, or medical conditions, who on 11Mar05 was vaccinated SC with a first dose of varicella virus vaccine live. Concomitant therapy included acyclovir (Zovirax). Approx 2 wks after vaccination, on approx 26Mar05 the pt experienced <50 vesicular rash on back and chest, (also reported as mild rash on abdomen and back). The pt had no pain and no fever. The pt was treated with acyclovir orally 5 times daily 5 to 7 days. The pt recovered within 2 weeks, on 06Apr05 from the vesicular rash. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information is not expected.
blood pressure spike of 147/89 10 minutes after booster; This spontaneous case was reported by a patient and describes the occurrence of BLOOD PRESSURE INCREASED (blood pressure spike of 147/89 10 minutes after booster) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040D21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS, NICOTINIC ACID (NIACIN), OMEPRAZOLE, FISH LIVER OIL and PARACETAMOL (TYLENOL [PARACETAMOL]) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure spike of 147/89 10 minutes after booster). At the time of the report, BLOOD PRESSURE INCREASED (blood pressure spike of 147/89 10 minutes after booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Oct-2021, Blood pressure increased: high (High) Patient reports his normal blood pressure reading is 118 to 122/78 to 82. However, now he is getting a blood pressure spike of 147/89..         Patient received the Moderna COVID-19 booster dose. While sitting at the pharmacy 10 minutes after the vaccine, patient took his blood pressure and got very high reading.  Patient reports he took his blood pressure a few more times on the machine and went down after relaxing. He has a manual blood pressure reader at home, so an hour later, he got back and has been relaxing, but his blood pressure was still high.  Patient took Tylenol before got home  and went to bed with no problems for the last 2 doses of the vaccine. He also took Tylenol this morning, as well as his normal medication regimen. Patient reports he has never taken blood pressure medications.
FELT COLDER; FEEL SICK; FEVER; TIRED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced felt colder, feel sick, fever, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feel sick, fever, tired and felt colder was not reported. This report was non-serious.
04Feb90 pt vax w/ hepta B;  exp muscle weakness in both legs.  This was a 2nd dose in a series of 3 doses.
Hep A given in left deltoid - pt observed for 15 minutes - no immediate reactions noted as per mom pt fell in clinic and hit her chin on floor - as per mom she attributes the fall to the child passing out after receiving vaccine.
first dose 2.5 years before, not received dose two; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-JUN-2022  Reporter's comment: The physician reported a patient received first dose of Shingrix two and a half years before this report and had not received dose two. The reporter consented to follow up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. This case was linked with case US2022099884, reported by same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2022099884:Same reporter
ROSTER SAID HIGH DOSE INFLUENZA VACCINE. THIS RN CONFIRMED CLIENT WANTED HIGH DOSE INFLUENZA VACCINE. VACCINE WAS ADMINISTERED TO PATIENT. CLIENT TOLERATED WELL. THIS RN WAS NOTIFIED THAT CLIENT'S INSURANCE WOULD NOT COVER VACCINE INJECTION DUE TO CLIENT IS ONLY 61 AND HIGH DOSE IS FOR 65 YEARS AND OLDER CLIENTS. CLIENT HAS  NOT REPORTED ANY ADVERSE PHYSICAL EFFECTS FROM THE VACCINE INJECTION.
29MAY93 pt presented w/petechiae & burises x 3 days; CBC revealed idiopathic thrombocytopenic purpura; there was no preceeding illness;